These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 27507559)

  • 1. The increased level of COX-dependent arachidonic acid metabolism in blood platelets from secondary progressive multiple sclerosis patients.
    Morel A; Miller E; Bijak M; Saluk J
    Mol Cell Biochem; 2016 Sep; 420(1-2):85-94. PubMed ID: 27507559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Flavonolignans inhibit the arachidonic acid pathway in blood platelets.
    Bijak M; Saluk-Bijak J
    BMC Complement Altern Med; 2017 Aug; 17(1):396. PubMed ID: 28797264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic variation in cyclooxygenase 1: effects on response to aspirin.
    Halushka MK; Walker LP; Halushka PV
    Clin Pharmacol Ther; 2003 Jan; 73(1):122-30. PubMed ID: 12545150
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutathione disulfide production during arachidonic acid oxygenation in human platelets.
    Burch JW; Burch PT
    Prostaglandins; 1990 Feb; 39(2):123-34. PubMed ID: 2107565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect.
    Remuzzi G; Benigni A; Dodesini P; Schieppati A; Livio M; De Gaetano G; Day SS; Smith WL; Pinca E; Patrignani P; Patrono C
    J Clin Invest; 1983 Mar; 71(3):762-8. PubMed ID: 6298281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arachidonic acid metabolism in the neonatal platelet.
    Stuart MJ; Allen JB
    Pediatrics; 1982 Jun; 69(6):714-8. PubMed ID: 6804924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.
    Bloom A; Greaves M; Preston FE; Brown CB
    Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arachidonic acid metabolism by platelets of differing size.
    Jakubowski JA; Thompson CB; Vaillancourt R; Valeri CR; Deykin D
    Br J Haematol; 1983 Mar; 53(3):503-11. PubMed ID: 6402003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of aspirin and indobufen in healthy volunteers.
    Lee JY; Sung KC; Choi HI
    Platelets; 2016; 27(2):105-9. PubMed ID: 26083594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term untreated streptozotocin-diabetes leads to increased expression and elevated activity of prostaglandin H2 synthase in blood platelets.
    Siewiera K; Kassassir H; Talar M; Wieteska L; Watala C
    Platelets; 2016; 27(3):203-11. PubMed ID: 26325148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-dependent formation of the isoprostane, 8-epi prostaglandin F2 alpha.
    Pratico D; Lawson JA; FitzGerald GA
    J Biol Chem; 1995 Apr; 270(17):9800-8. PubMed ID: 7730359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vinca alkaloids inhibit conversion of arachidonic acid to thromboxane by human platelet microsomes: comparison with other microtubule-active drugs.
    Maguire MH; Csonka-Khalifah L
    Biochim Biophys Acta; 1987 Oct; 921(3):426-36. PubMed ID: 3117116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of PAF on the metabolization of arachidonic acid by human blood platelets.
    Ostermann G; Block HU; Till U
    Biomed Biochim Acta; 1984; 43(8-9):S323-6. PubMed ID: 6440547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet lipoxygenase-dependent oxygen burst. Evidence for differential activation of lipoxygenase in intact and disrupted human platelets.
    Schafer AI; Turner NA; Handin RI
    Biochim Biophys Acta; 1982 Sep; 712(3):535-41. PubMed ID: 6812645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arachidonic acid-stimulated platelet tests: Identification of patients less sensitive to aspirin treatment.
    Temperilli F; Rina A; Massimi I; Montemari AL; Guarino ML; Zicari A; Pulcinelli FM
    Platelets; 2015; 26(8):783-7. PubMed ID: 25734355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcellular activation of platelets and endothelial cells by bioactive lipids in platelet microparticles.
    Barry OP; Pratico D; Lawson JA; FitzGerald GA
    J Clin Invest; 1997 May; 99(9):2118-27. PubMed ID: 9151784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of cyclooxygenase-1-dependent and -independent platelet function assays with adverse clinical outcomes in aspirin-treated patients presenting for cardiac catheterization.
    Frelinger AL; Li Y; Linden MD; Barnard MR; Fox ML; Christie DJ; Furman MI; Michelson AD
    Circulation; 2009 Dec; 120(25):2586-96. PubMed ID: 19996015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
    Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
    Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of inhibition of cyclo-oxygenase in human blood platelets by carbamate insecticides.
    Krug HF; Hamm U; Berndt J
    Biochem J; 1988 Feb; 250(1):103-10. PubMed ID: 3128272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients.
    Morel A; Rywaniak J; Bijak M; Miller E; Niwald M; Saluk J
    Mol Cell Biochem; 2017 Jun; 430(1-2):69-80. PubMed ID: 28210898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.